Investigating tDCS as a Treatment for Unipolar and Bipolar Depression
One of the largest tDCS trials for depression is about to kick off. Marking a milestone in tDCS effectiveness research for both Unipolar and Bipolar depression.
The University of New South Wales, along with Duke University, Emory University, Sheppard Pratt Health System, University of Medicine and Dentistry New Jersey and the University of Texas are embarking on a large scale trial for the treatment of both unipolar and bipolar depression with tDCS. This is the largest multi-center tDCS trial to date. It is led by Dr. Colleen Loo from the Black Dog Institute at the University of New South Wales
The study will investigate the effectiveness of tDCS as a treatment for Unipolar and Bipolar Depression in an expected number of 120 volunteers who suffer from depression. The recruiting of candidates is ongoing, with completion of the study to be expected in March 2015.
To enquire about participating in the trial, contact TMSandDCS@unsw.edu.au